Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Condition: Gestational Trophoblastic Neoplasia Interventions: Drug: Camrelizumab plus apatinib CohortA; Drug: Camrelizumab plus apatinib Cohort B Sponsors: Peking Union Medical College Hospital; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials